Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
252
NCT01230138
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2010
Completion: May 31, 2012
NCT01815723
Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
Phase: Phase 3
Start: Jun 30, 2016
Completion: Jun 30, 2017